Related Experiment Video

Updated: Jul 10, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis

Everardo Macias1, Yongbaek Kim, Paula L Miliani de Marval

  • 1Center for Comparative Medicine and Translational Research, Department of Molecular Biomedical Sciences, North Carolina State University, Raleigh, North Carolina 27606, USA.

Cancer Research
|October 19, 2007
PubMed

Insights

Cyclin-dependent kinase 2 (CDK2) ablation reduces squamous cell carcinoma (SCC) in mouse models with ras-driven tumors. However, CDK2 is not essential for myc-driven tumor development, indicating pathway-specific roles in tumorigenesis.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cancer Research

Background:

  • Previous studies demonstrated CDK4's role in promoting SCC development and dependence of myc-induced proliferation on CDK4.
  • Keratinocyte proliferation is linked to CDK4 sequestering p27Kip1 and p21Cip1, activating CDK2.
  • The specific role of CDK2 in epithelial tumorigenesis remained to be elucidated.

Purpose of the Study:

  • To investigate the role of CDK2 in epithelial tumorigenesis.
  • To determine if CDK2 is essential for CDK4-induced or myc-induced tumor development and progression.
  • To assess the impact of CDK2 ablation on tumor susceptibility and malignant progression in different oncogenic contexts.

Main Methods:

  • Utilized genetically modified mouse models (K5CDK4, K5Myc, and their CDK2-ablated counterparts).
  • Employed chemical carcinogenesis protocols to induce skin papilloma and SCC development.
  • Conducted histopathologic analysis to evaluate tumor aggressiveness and progression.

Main Results:

  • Loss of CDK2 rescued CDK4-induced epidermal hyperproliferation but not myc-induced hyperproliferation in normal skin.
  • Ablation of CDK2 in K5CDK4 mice significantly decreased tumor incidence, multiplicity, and malignant progression to SCC.
  • CDK2 was dispensable for myc-induced tumorigenesis, with K5Myc/CDK2-/- mice developing oral tumors at rates similar to K5Myc mice.

Conclusions:

  • Ras-induced tumors are more sensitive to CDK2 ablation than myc-induced tumors.
  • The efficacy of targeting CDK2 in cancer therapy is dependent on the specific oncogenic pathway driving tumor development.
  • CDK2 plays a critical role in CDK4-mediated, but not myc-mediated, epithelial tumorigenesis and malignant progression.

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.